A genomic classifier for prostate cancer correlates with adverse pathologic features: Transcriptomic features of cribriform and intraductal carcinoma of the prostate. This is an ASCO Meeting Abstract ...
The AI Classifier’s end came not with a bang, but a whimper. Rather than announcing the change in a statement, OpenAI took down AI Classifier’s landing page ...
A systematic review found that genomic classifier tests can influence risk assessments and treatment decisions among patients with localized prostate cancer but studies evaluating these tests vary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results